Stock AnalizBrightSpring Health Services (BTSG) earnings for the quarter ended September 2026: EPS beats estimates
BrightSpring Health Services reported results for the quarter ended September 2026 on October 30, 2026. Adjusted earnings per share came in at $0.54 against the analysts’ average forecast of $0.47, a beat of 14.7%.
Revenue for the quarter was $4.21 billion, up 26.4% from $3.33 billion in the same quarter a year earlier.
The market’s verdict: the stock rose 11.1% on the first trading day after the report.
The last four quarters
BrightSpring Health Services has beaten the analysts’ EPS forecast in 3 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $0.54 | $0.47 | +14.7% | +26% | +11.1% |
| Jun 2026 | $0.45 | $0.40 | +13.0% | +23% | −17.0% |
| Mar 2026 | $0.39 | $0.31 | +26.1% | +26% | +11.6% |
| Dec 2025 | $0.33 | $0.35 | −4.7% | −10% | +3.6% |
What comes next
Analysts expect EPS of $0.54 for the next quarter on average and $1.92 for the fiscal year ending December 31, 2026.
The average analyst price target is $83.21, 17% above the current price of $71.21.
Valuation and score
BrightSpring Health Services scores 1.2 out of 5 overall on Stock Analiz (weak), trades at a trailing P/E of about 50.5, and its intrinsic value under moderate assumptions is about 10% below the current market value. Full BrightSpring Health Services analysis with 10 years of financials
Frequently asked questions
What was BrightSpring Health Services’s EPS for the quarter ended September 2026?
$0.54 adjusted per share, against an analyst consensus of $0.47.
How much revenue did BrightSpring Health Services report?
$4.21 billion, up 26.4% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.